VER-01 for Chronic Low Back Pain (CLBP)
Chronic Low Back Pain
Phase 3Active - Filed for registration in Germany
Key Facts
Indication
Chronic Low Back Pain
Phase
Phase 3
Status
Active - Filed for registration in Germany
Company
About Vertanical
Vertanical is a clinical-stage biopharma company pioneering cannabinoid-based treatments for chronic pain. Its lead candidate, VER-01, is in late-stage development for chronic low back pain, with a marketing application submitted in Germany, and has additional planned programs for osteoarthritis and painful diabetic neuropathy. The company operates an advanced GMP manufacturing facility and runs a robust clinical program across Europe and the US, positioning itself as a potential disruptor in the global pain management market, which affects over a billion people.
View full company profileTherapeutic Areas
Other Chronic Low Back Pain Drugs
| Drug | Company | Phase |
|---|---|---|
| SPRINT PNS for Chronic Low Back Pain | SPR Therapeutics | Approved |
| Rexlemestrocel-L | Sumitomo Pharma | Phase 3 |